Screener
Merck & Co. MRK Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfDebt.
The source filing: Merck & Co.’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:15 PM EST
- Fiscal year
- FY2026
- Accession
- 0000310158-26-000063
| Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Cash Used in Investing Activities | (13,741) | (7,734) | (14,083) |
| Cash Flows from Financing Activities | |||
| Payments on debt | (2,503) | (1,290) | (1,755) |
| Proceeds from issuance of debt | 13,880 | 3,599 | 5,939 |
| Purchases of treasury stock | (5,084) | (1,306) | (1,346) |
| Dividends paid to stockholders | (8,176) | (7,840) | (7,445) |
| Proceeds from exercise of stock options | 92 | 177 | 125 |
| Other | (131) | (372) | (328) |
Item 8.Financial Statements and Supplementary Data.
FAQ
- What is Merck & Co.'s debt issuance proceeds?
- Merck & Co. (MRK) reported debt issuance proceeds of $7.92B in Q4 2025.
- How has Merck & Co.'s debt issuance proceeds changed year-over-year?
- Merck & Co.'s debt issuance proceeds increased by 780.0% year-over-year, from $899.75M to $7.92B.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Merck & Co.'s debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude